X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

- test

Biomarkers of apalutamide response identified in nonmetastatic CRPC

medwireNews: Further analysis of patients with nonmetastatic castration-resistant prostate cancer (CRPC) from the SPARTAN trial has identified molecular biomarkers associated with... Read More

Study highlights PSA screening gaps for transgender people

medwireNews: US researchers report a lower uptake of prostate-specific antigen (PSA) screening by transgender individuals than cisgender straight men. However,... Read More

HSD3B1 Variant May Predict Treatment Response in Advanced Prostate Cancer

The HSD3B1 1245C variant allele could be used as a biomarker to predict treatment response in different groups of men... Read More